You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 20, 2024

CLINICAL TRIALS PROFILE FOR PRX-03140

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for PRX-03140

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00384423 ↗	Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept	Completed	Epix Pharmaceuticals, Inc.	Phase 2	This is a study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PRX-03140 administered orally once daily for 14 days in subjects with mild Alzheimer's Disease who are using a stable, well-tolerated 10 mg dose of Aricept (donepezil) but continue to experience worsening AD symptoms.
NCT00672945 ↗	A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil	Terminated	Epix Pharmaceuticals, Inc.	Phase 2	A randomized placebo-controlled study to evaluate the efficacy of PRX-03140 in subjects with Alzheimer's Disease receiving a stable dose of donepezil. The study consists of a 26-week double-blind treatment period.
NCT00693004 ↗	Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease	Terminated	Epix Pharmaceuticals, Inc.	Phase 2	A randomized placebo-controlled study to evaluate the efficacy of PRX-03140 monotherapy in subjects with Alzheimer's disease. The study consists of a 3-month double-blind treatment period and an optional 3-month extension period.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for PRX-03140

Condition Name

Chart
Table

Condition Name for
Intervention	Trials
Alzheimer's Disease	3
Post Traumatic Stress Disorder	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for
Intervention	Trials
Alzheimer Disease	3
Stress Disorders, Traumatic	1
Stress Disorders, Post-Traumatic	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for PRX-03140

Trials by Country

Map
Table

Trials by Country for
Location	Trials
United States	44
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for
Location	Trials
Florida	4
Oklahoma	3
Ohio	3
Massachusetts	3
Louisiana	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for PRX-03140

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for
Clinical Trial Phase	Trials
Phase 2	3
N/A	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for
Clinical Trial Phase	Trials
Completed	2
Terminated	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for PRX-03140

Sponsor Name

Chart
Table

Sponsor Name for
Sponsor	Trials
Epix Pharmaceuticals, Inc.	3
Nanotherapeutics, Inc.	1
Ology Bioservices	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for
Sponsor	Trials
Industry	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.